DEC 05, 2018 09:00 AM PST

Zika virus as a weapon against brain cancer

Glioblastoma is the most aggressive type of Brain Cancer, with an average survival rate of fewer than two years with treatment. So what if there could be a cure for this type of cancer.

Researchers at the University of Texas Medical Branch at Galveston led by geneticist Pei-Yong Shi successfully used a Zika virus vaccine to target and kill glioblastoma in mice, the research was published in MBio

Zika virus was identified in Uganda in 1947, it is spread by mosquito bites and causes fever, rash, joint pain, and it can be passed from pregnant women to their fetus causing a condition called microcephaly where the fetal brain does not fully develop.

Zika virus causes microcephaly by attacking stem cells in the fetal brain, on the other hand, Glioblastoma affects glial cells in the brain which are similar to fetal stem cells that Zika attacks. These observations led the scientists to try to develop altered Zika vaccine that attacks cancerous glial cells instead of brain stem cells.

The study showed that Zika vaccine shrunk the tumor size in mice suffering from glioblastoma without any neurological damage.

This research gives hope in finding a cure for glioblastoma.

Sources: Youtube, UTMB

About the Author
  • A master student in Biochemistry and Molecular biology with experience in Education and Research. I am passionate about scientific research and passing my knowledge to others to help them learn about the latest in science by teaching, writing and volunteering in scientific events.
You May Also Like
NOV 14, 2018
Cancer
NOV 14, 2018
How Cancer's 'Invisibility Cloak' Works
One of cancer’s cunning strategies to evade death is to make itself invisible to the immune system. Now researchers say they’ve identified the...
JUL 12, 2018
Infographics
JUL 12, 2018
3D Imaging Advantage
Learn about the advantages and the technology behind 3D cellular image acquisition and analysis with this infographic from Molecular Devices....
JUL 31, 2018
Cancer
JUL 31, 2018
Protein Regulation of DNA Replication in Cancer Cells - A New Early Target for Broad Therapeutics?
DNA replication is a carefully regulated process in each cell of the body. Researchers are looking at the mechanism of DNA replication and associated proteins as a therapy target in cancer...
AUG 08, 2018
Immunology
AUG 08, 2018
Doxorubicin Causes Heart Toxicity by Immune System Disruption
Chemotherapy drug Doxorubicin disrupts metabolism that controls immune responses in the heart leading to heart toxicity....
OCT 05, 2018
Cancer
OCT 05, 2018
FDA approves a new drug for an advanced type of skin cancer
As cancer is one of the most challenging diseases in our world, many efforts have been put into researching new ways for treatment to find new drugs that could help more patients worldwide. A...
NOV 15, 2018
Drug Discovery
NOV 15, 2018
Making Cancer Disappear?
Neuroblastoma is one of the most common childhood cancers and the leading cause of cancer deaths among pediatric patients younger than 5. The cancer is fre...
Loading Comments...